Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions - Wikidata - wikimedia - TriplyDB

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

http://www.wikidata.org/entity/Q28252652

about

sameAs

Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia Genetics of lipid traits and relationship to coronary artery disease The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of l Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Expression of human hepatic lipase negatively impacts apolipoprotein A-I production in primary hepatocytes from Lipc-null mice.Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.Complexities of plasma apolipoprotein C-III metabolism Genetic determinants of plasma triglycerides Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance.Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis Hepatic ABCA1 and VLDL triglyceride production.Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.Differential effects of low-fat and high-fat diets on fed-state hepatic triacylglycerol secretion, hepatic fatty acid profiles, and DGAT-1 protein expression in obese-prone Sprague-Dawley rats.Lipoprotein metabolism in nonalcoholic fatty liver disease Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.Metabolic Characterization of a Rare Genetic Variation Within APOC3 and Its Lipoprotein Lipase-Independent Effects.Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.Antisense technology: an emerging platform for cardiovascular disease therapeutics.Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph Lipids and HCV.Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease.Key differences between apoC-III regulation and expression in intestine and liver.Experimental Biology for the Identification of Causal Pathways in Atherosclerosis.Targeting ApoC-III to Reduce Coronary Disease Risk.ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition.A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII.

P2860

Q26743466-80C356B5-C3BD-4093-889D-EAA0385DF6C1 Q26864682-9957936A-CAC1-4507-8015-C118DF47B055 Q26995252-FEFC1323-9A4B-4235-9326-5AEC19EE6D88 Q28072835-094245E9-7664-44F1-9BFD-08BC4C1B19EE Q28240856-F76CA78C-5D71-4055-878C-7AED70F67675 Q28271254-5373024E-C3B8-4006-AC2A-6A240091E61B Q33858526-8A4C35DB-5DA1-42E6-A1C6-3B3E8DEB4CFB Q33858537-463ACE75-B79B-490C-BD2A-FF0A80801C0D Q33863614-EB4F79C3-D666-4D3B-A671-4E5151D47486 Q34172178-08DD23ED-6ACB-4AA4-BDFD-675F269B10A9 Q34503333-685A73DC-9478-4281-8C97-FEA92807850B Q34551430-1FBBAF4F-C567-4FC1-8101-4E6A4D86C5AC Q34800989-49FC2BFB-0F24-4786-9F61-BBE437931104 Q35157797-DA0CBDED-6F5B-423F-9FDD-022A395D0ABF Q35186665-93241E31-BBFB-49E2-9F77-8F3D70186483 Q35489364-E13CA512-D9A8-4C04-A4CC-4D50D43E59AB Q35687045-015FE16C-5153-4167-B692-125AB2060CCB Q35737630-C78B2954-4647-41A9-BB45-C239C8228547 Q35771163-486A2292-ABA3-491F-9E9E-85456D6E75E7 Q35915137-DF8CD1A4-FE2A-4DC7-98E2-8855E247016B Q36438766-1D914E80-63BE-407F-A950-C0370F323AAC Q36682138-98DFD1D6-31D0-4746-BC7C-27BDD59BE6D7 Q36843331-2655156B-CCB9-4848-8162-9B60A27C27D5 Q36956660-5E02AAB7-A843-4A81-AC0F-9DE8181DBF7D Q37036336-3B7ABC79-8A2F-4D41-85D2-DAF9FF813B54 Q37333795-7912CDA9-42CC-486F-BCD7-FCF121E6D477 Q37337608-A4F80F92-597F-486F-9D66-2345490C56AD Q37727877-CEB485D7-A7A1-4189-8EC8-A7BD7526B737 Q38056643-1B3E4C43-9DAC-4494-B608-7C44E9455AF8 Q38212276-0C045FE1-25A2-4C16-964C-D27258309A45 Q38664013-217E6E46-35C6-45DF-8A1F-9F8BACEE6EEA Q38723704-11078E3E-0035-4498-8E66-486ACA62DA3F Q38904497-EB8BC322-F259-445C-B3EB-3223B3A5A886 Q39614082-26F80E8B-AF46-49A9-A513-BFC3E75CA579 Q39614897-B7435C31-8B80-4BC1-858F-17055303F22D Q40350510-05CAB398-CA57-42EF-B1EC-6E8EC6EE30C0 Q40887732-D19AAC79-F076-4804-8E4D-B70A8B22CA68 Q41063014-C9536013-6389-40BB-9279-14623B01FB7D Q42981153-2526976F-D13A-495F-98F3-676EA68FDC80 Q46702771-EFE6C2C2-5F69-48E0-B0C3-350D9B0F9998

P2860

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

http://www.wikidata.org/entity/Q28252652

description

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Expression of apolipoprotein C ...... on under lipid-rich conditions

@ast

Expression of apolipoprotein C ...... on under lipid-rich conditions

@en

Expression of apolipoprotein C ...... on under lipid-rich conditions

@nl

type

label

Expression of apolipoprotein C ...... on under lipid-rich conditions

@ast

Expression of apolipoprotein C ...... on under lipid-rich conditions

@en

Expression of apolipoprotein C ...... on under lipid-rich conditions

@nl

prefLabel

Expression of apolipoprotein C ...... on under lipid-rich conditions

@ast

Expression of apolipoprotein C ...... on under lipid-rich conditions

@en

Expression of apolipoprotein C ...... on under lipid-rich conditions

@nl

P1433

Q28252652-9860921C-7067-49E4-AC51-1952F64681F5

P1476

Q28252652-441B1436-F5AF-4C04-8A49-AE02DC01DE22

P2093

Q28252652-0279BD6A-AE8B-4962-8C41-88345BA3B05D

Q28252652-0647DAD5-3806-423E-A007-8AE34906D330

Q28252652-208AE99E-669D-4399-B2CE-3162532F358B

Q28252652-31474316-C6DB-417F-A50B-310439DB9FBE

Q28252652-3CA31817-4114-4672-9FFC-B41F47DBFC09

Q28252652-3EE21B18-7929-46E4-9584-D1FB77F8B4FD

Q28252652-4E37C92D-69AB-47F3-B28D-CC6B01F7B4D5

Q28252652-5BB9C2CF-2871-4BFE-AB52-DC62027A369A

Q28252652-64A10EDD-A1B0-4CDF-8156-6313726DD694

Q28252652-656EA10F-3EFD-40A7-B600-4D9BE4083E6C

P2860

Q28252652-0E1FD86C-1F1C-4158-98EA-A683FC548DC2

Q28252652-11D186FA-D85D-4CF0-98F6-1D3442981A0B

Q28252652-19518D8A-A2D0-41EB-BD35-638BE1F700C7

Q28252652-19D802A6-8EE3-4891-9B7E-5847948B9630

Q28252652-272D1412-5F07-404C-BE88-3F65EA0B85CC

Q28252652-27A0D474-E432-4ED4-8B47-7B6410CB568A

Q28252652-2B8AD749-8F45-4A4F-99A5-930B607C11D5

Q28252652-2BE7B0D8-7E65-40C7-B5F5-BACD68E692FF

Q28252652-30A19639-3613-4ADE-8019-22338FF90FC5

Q28252652-382BD0E1-FD44-4632-817A-489D00AF3DCB

P304

Q28252652-26745F88-6115-434E-AD60-1BC206D90A58

Q28252652-3ACE75A3-85B1-4980-95FF-56810A89DBDA

P31

Q28252652-2DBAA6DB-2283-4C64-95D7-3CFDEBCF54EF

P3181

Q28252652-54489F58-8DC6-4D9E-A25C-13F8C564CDFD

P356

Q28252652-921DEF87-AE9A-420A-8A6F-9ADD7816EBDB

P407

Q28252652-C2591D94-2809-4923-A17E-02F50DEA7190

P433

Q28252652-C11E2EF5-2F64-4622-A1EA-A4A05BDD33F4

P478

Q28252652-D576C7FB-FCF4-4FA7-AC67-D33C1A772454

P577

Q28252652-7AC66D4B-3A05-41A5-B140-8588FF777469

Q28252652-A4E8D535-3784-4F2F-99E5-774DA20E58AF

P5875

Q28252652-208578F7-8EAE-48F0-89D9-F424BA3473CB

P698

Q28252652-066BBB63-2174-41DF-BBED-31452326DE1B

P932

Q28252652-FA3E8F2F-747F-4EC2-A137-9C557A45594D

P3181

P356

P1433

Journal of Lipid Research

P1476

Expression of apolipoprotein C ...... on under lipid-rich conditions

@en

P2093

J. Iqbal

http://www.w3.org/2001/XMLSchema#string

Jahangir Iqbal

http://www.w3.org/2001/XMLSchema#string

M Mahmood Hussain

http://www.w3.org/2001/XMLSchema#string

M. B. Khalil

http://www.w3.org/2001/XMLSchema#string

M. M. Hussain

http://www.w3.org/2001/XMLSchema#string

M. Sundaram

http://www.w3.org/2001/XMLSchema#string

Maroun Bou Khalil

http://www.w3.org/2001/XMLSchema#string

Meenakshi Sundaram

http://www.w3.org/2001/XMLSchema#string

P. H. Links

http://www.w3.org/2001/XMLSchema#string

Philip H Links

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Structure and dynamics of human apolipoprotein CIII

High-efficiency transformation of mammalian cells by plasmid DNA

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia

P304

150-161

http://www.w3.org/2001/XMLSchema#string

150-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1986206

http://www.w3.org/2001/XMLSchema#string

P356

10.1194/M900346-JLR200

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26686424

http://www.w3.org/2001/XMLSchema#string

P698

19622837

http://www.w3.org/2001/XMLSchema#string

P932

2789775

http://www.w3.org/2001/XMLSchema#string